Sutureless anastomoses

More about the book

When doctors first encounter sutureless anastomosis devices, they often remark on how easy it is to perform vascular anastomosis, leading some to believe that anyone could become a cardiovascular surgeon. Conversely, pessimistic cardiovascular surgeons fear that machines capable of replicating their core activity—creating anastomoses—could threaten their profession. Despite frequent predictions of its demise, no medical specialty's decline has been more overstated than that of cardiovascular surgery. Critics have claimed that since the late 1980s, with the rise of angioplasty and later advancements like bare metal and drug-eluting stents, cardiovascular surgery has been on the brink of collapse. This decline has been attributed to the rise of percutaneous procedures that allow non-surgeon doctors to perform tasks traditionally reserved for surgeons. However, the reality is different. Data indicates that cardiac surgery continues to thrive, defying the anticipated decline. Economically, CABG remains a mature market with significant opportunities, as evidenced by approximately 1,500,000 procedures performed annually worldwide, totaling nearly 2.5 billion US dollars.